These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 7684805)
1. Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Cook EH; Arora RC; Anderson GM; Berry-Kravis EM; Yan SY; Yeoh HC; Sklena PJ; Charak DA; Leventhal BL Life Sci; 1993; 52(25):2005-15. PubMed ID: 7684805 [TBL] [Abstract][Full Text] [Related]
2. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers. Spigset O; Allard P; Mjörndal T Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533 [TBL] [Abstract][Full Text] [Related]
3. Platelet 5-HT2 serotonin receptor binding sites in autistic children and their first-degree relatives. Perry BD; Cook EH; Leventhal BL; Wainwright MS; Freedman DX Biol Psychiatry; 1991 Jul; 30(2):121-30. PubMed ID: 1912104 [TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of 5-hydroxyindoleacetic acid, serotonin and 6-sulphatoxymelatonin in normoserotonemic and hyperserotonemic autistic individuals. Mulder EJ; Anderson GM; Kemperman RF; Oosterloo-Duinkerken A; Minderaa RB; Kema IP Neuropsychobiology; 2010; 61(1):27-32. PubMed ID: 19923863 [TBL] [Abstract][Full Text] [Related]
5. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors. Hrdina PD; Bakish D; Chudzik J; Ravindran A; Lapierre YD J Psychiatry Neurosci; 1995 Jan; 20(1):11-9. PubMed ID: 7865496 [TBL] [Abstract][Full Text] [Related]
6. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. Arora RC; Meltzer HY Life Sci; 1989; 44(11):725-34. PubMed ID: 2927243 [TBL] [Abstract][Full Text] [Related]
7. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Bakish D; Cavazzoni P; Chudzik J; Ravindran A; Hrdina PD Biol Psychiatry; 1997 Jan; 41(2):184-90. PubMed ID: 9018388 [TBL] [Abstract][Full Text] [Related]
8. Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment. Bixo M; Allard P; Bäckström T; Mjörndal T; Nyberg S; Spigset O; Sundström-Poromaa I Psychoneuroendocrinology; 2001 Aug; 26(6):551-64. PubMed ID: 11403977 [TBL] [Abstract][Full Text] [Related]
9. Platelet serotonergic functions and light therapy in seasonal affective disorder. Stain-Malmgren R; Kjellman BF; Aberg-Wistedt A Psychiatry Res; 1998 May; 78(3):163-72. PubMed ID: 9657420 [TBL] [Abstract][Full Text] [Related]
10. Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. Cook EH; Leventhal BL; Heller W; Metz J; Wainwright M; Freedman DX J Neuropsychiatry Clin Neurosci; 1990; 2(3):268-74. PubMed ID: 2136085 [TBL] [Abstract][Full Text] [Related]
11. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Anderson GM; Gutknecht L; Cohen DJ; Brailly-Tabard S; Cohen JH; Ferrari P; Roubertoux PL; Tordjman S Mol Psychiatry; 2002; 7(8):831-6. PubMed ID: 12232775 [TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Cross S; Kim SJ; Weiss LA; Delahanty RJ; Sutcliffe JS; Leventhal BL; Cook EH; Veenstra-Vanderweele J Neuropsychopharmacology; 2008 Jan; 33(2):353-60. PubMed ID: 17406648 [TBL] [Abstract][Full Text] [Related]
13. Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine. Lawrence KM; Falkowski J; Jacobson RR; Horton RW Psychopharmacology (Berl); 1993; 110(1-2):235-9. PubMed ID: 7870891 [TBL] [Abstract][Full Text] [Related]
14. Platelet imipramine binding in autistic subjects. Anderson GM; Minderaa RB; van Benthem PP; Volkmar FR; Cohen DJ Psychiatry Res; 1984 Feb; 11(2):133-41. PubMed ID: 6584936 [TBL] [Abstract][Full Text] [Related]
15. Significant correlation between 14C-5-HT uptake by and 3H-paroxetine binding to platelets from healthy volunteers. Maguire K; Tuckwell V; Pereira A; Dean B; Singh B Biol Psychiatry; 1993 Sep; 34(6):356-60. PubMed ID: 8218602 [TBL] [Abstract][Full Text] [Related]
16. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine. Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618 [TBL] [Abstract][Full Text] [Related]
17. Relationships of whole blood serotonin and plasma norepinephrine within families. Leventhal BL; Cook EH; Morford M; Ravitz A; Freedman DX J Autism Dev Disord; 1990 Dec; 20(4):499-511. PubMed ID: 2279970 [TBL] [Abstract][Full Text] [Related]
18. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets. Williams KA; Murphy W; Haslam RJ Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206 [TBL] [Abstract][Full Text] [Related]
19. Platelet serotonin functions in untreated major depression. Neuger J; El Khoury A; Kjellman BF; Wahlund B; Aberg-Wistedt A; Stain-Malmgren R Psychiatry Res; 1999 Feb; 85(2):189-98. PubMed ID: 10220009 [TBL] [Abstract][Full Text] [Related]
20. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics. Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]